Skip to Main Content

Author Details

Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
1981
389
83
PMIDPaper TitleJournal TitlePublished Year
36732510HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC.Nat Commun2023
37774124Regulation of Immune Homeostasis, Inflammation, and HIV Persistence by the Microbiome, Short-Chain Fatty Acids, and Bile Acids.Annu Rev Virol2023
37723971Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.Elife2023
37024448TREM2<sup>+</sup> and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques.Nat Commun2023
37406029Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.PLoS Negl Trop Dis2023
37399354Carbohydrate ligand engagement with CD11b enhances differentiation of tumor-associated myeloid cells for immunotherapy of solid cancers.J Immunother Cancer2023
37030290CD8<sup>+</sup> T cells promote HIV latency by remodeling CD4<sup>+</sup> T cell metabolism to enhance their survival, quiescence, and stemness.Immunity2023
37327781Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients.Cell Rep Med2023
36865336<i>Schistosoma mansoni</i> infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.medRxiv2023
35104248IFN-α blockade during ART-treated SIV infection lowers tissue vDNA, rescues immune function, and improves overall health.JCI Insight2022
35765315Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.Open Forum Infect Dis2022
35371104Chronic Alcohol Exposure Among People Living with HIV Is Associated with Innate Immune Activation and Alterations in Monocyte Phenotype and Plasma Cytokine Profile.Front Immunol2022
35421620Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.Transplant Cell Ther2022
36215260Cocaine use associated gut permeability and microbial translocation in people living with HIV in the Miami Adult Study on HIV (MASH) cohort.PLoS One2022
35907675Innate antiviral immunity: how prior exposures can guide future responses.Trends Immunol2022
36266291The Immune Signatures data resource, a compendium of systems vaccinology datasets.Sci Data2022
36316476Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.Nat Immunol2022
36316475Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.Nat Immunol2022
33693561Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus.Clin Infect Dis2022
35316209Gut-derived bacterial toxins impair memory CD4+ T cell mitochondrial function in HIV-1 infection.J Clin Invest2022
35033954Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV.Drug Alcohol Depend2022
35032866Induction of thymic atrophy and loss of thymic output by type-I interferons during chronic viral infection.Virology2022
35210622Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.Nat Immunol2022
35061851Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine.PLoS Pathog2022
35271506Lymph node CXCR5+ NK cells associate with control of chronic SHIV infection.JCI Insight2022
34902803Translating known drivers of COVID-19 disease severity to design better SARS-CoV-2 vaccines.Curr Opin Virol2022
34871809Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection.Transl Res2022
35080914Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.Sci Transl Med2022
35230978Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy.J Clin Invest2022
33037877Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs.J Infect Dis2021
33720048NLRP3 inflammasome induces CD4+ T cell loss in chronically HIV-1-infected patients.J Clin Invest2021
33767427Multi-omics analyses reveal that HIV-1 alters CD4<sup>+</sup> T cell immunometabolism to fuel virus replication.Nat Immunol2021
33903232Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures.Proc Natl Acad Sci U S A2021
33868267Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children.Front Immunol2021
35097250Is France Once Again Looking for a Scapegoat?Pathog Immun2021
34893603Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.Nat Commun2021
34556879The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccination.Nat Immunol2021
34642693TREM2+ and interstitial macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques.bioRxiv2021
34610295Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.Cell Host Microbe2021
34449812Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.PLoS Pathog2021
34712233Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma.Front Immunol2021
34559866TCA cycle remodeling drives proinflammatory signaling in humans with pulmonary tuberculosis.PLoS Pathog2021
34385425Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.Cell Death Dis2021
34039845"Go", "No Go," or "Where to Go"; does microbiota dictate T cell exhaustion, programming, and HIV persistence?Curr Opin HIV AIDS2021
34244611Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression.Leukemia2021
34012439Neonatal T Helper 17 Responses Are Skewed Towards an Immunoregulatory Interleukin-22 Phenotype.Front Immunol2021
34266981A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.Sci Immunol2021
34237254Translocated microbiome composition determines immunological outcome in treated HIV infection.Cell2021
34228762Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.PLoS Pathog2021
33278358Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques.Cell2021
  • 1 - 50 of 389

Recommended Authors

University of Alabama at Birmingham
Career Start Year 2014
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 12
J. David Gladstone Institutesgrid.249878.8
Career Start Year 2011
Number of shared co-authors 9
University of Illinois at Chicago
Career Start Year 2008
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 2005
Number of shared co-authors 7
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 6
Vitalant Research Institute
Career Start Year 2001
Number of shared co-authors 15
George Washington University
Career Start Year 2000
Number of shared co-authors 6
Center for Infectious Medicine, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 12
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 2
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 2
College of Medicine, University of Arizona
Career Start Year 1994
Number of shared co-authors 10
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 3
Duke University School of Medicine
Career Start Year 1992
Number of shared co-authors 4
Albert Einstein College of Medicine
Career Start Year 1992
Number of shared co-authors 2
University of Utah
Career Start Year 1991
Number of shared co-authors 9
Yale University
Career Start Year 1990
Number of shared co-authors 13
Oxford University.
Career Start Year 1984
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 6
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 11
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 24
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 11
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1977
Number of shared co-authors 3
University of California
Career Start Year 1976
Number of shared co-authors 1
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 15
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 14
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 2
Gladstone Institute of Virology, USA University of California san francisco
Career Start Year 1971
Number of shared co-authors 22

Collaborators

Co-authored papers 19
Co-authored papers 16
University of California san francisco
Co-authored papers 15
Co-authored papers 12
Co-authored papers 11
Case Western Reserve University
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Ragon Institute of Mass General
Co-authored papers 9
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Co-authored papers 9
Co-authored papers 8
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
University of Virginia
Co-authored papers 7
Faculte de pharmacie, Universite Laval
Co-authored papers 6
Merck & Co. Inc.
Co-authored papers 6
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers 6
Frederick National Laboratory
Co-authored papers 6
Co-authored papers 6
Institute for Research in Immunology and Cancer
Co-authored papers 6
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
Columbia University
Co-authored papers 4
Co-authored papers 4